Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets EXMKT - Delayed Quote USD

Talis Biomedical Corporation (TLIS)

1.6000
0.0000
(0.00%)
At close: April 25 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
300
412
3,652
--
--
Cost of Revenue
20
41
8,391
--
--
Gross Profit
280
371
-4,739
--
--
Operating Expense
55,402
67,186
110,400
191,816
91,184
Operating Income
-55,122
-66,815
-115,139
-191,816
-91,184
Net Non Operating Interest Income Expense
--
--
--
--
54
Other Income Expense
4,096
4,808
2,127
-220
54
Pretax Income
-51,026
-62,007
-113,012
-192,036
-91,130
Net Income Common Stockholders
-51,026
-62,007
-113,012
-192,036
-91,130
Diluted NI Available to Com Stockholders
-51,026
-62,007
-113,012
-192,036
-91,130
Basic EPS
-28.02
-34.12
-63.26
-109.08
-69.46
Diluted EPS
-28.02
-34.12
-63.26
-109.08
-69.46
Basic Average Shares
1,821.1270
1,817.5060
1,786.3860
1,760.5350
1,311.9910
Diluted Average Shares
1,821.1270
1,817.5060
1,786.3860
1,760.5350
1,311.9910
Total Operating Income as Reported
-55,122
-66,815
-115,139
-191,816
-91,184
Total Expenses
55,422
67,227
118,791
191,816
91,184
Net Income from Continuing & Discontinued Operation
-51,026
-62,007
-113,012
-192,036
-91,130
Normalized Income
-51,026
-62,007
-113,012
-192,036
-91,130
Interest Income
--
--
--
--
54
Net Interest Income
--
--
--
--
54
EBIT
-55,122
-66,815
-115,139
-191,816
-91,184
EBITDA
-54,348
-66,045
-106,309
-190,238
-90,421
Reconciled Cost of Revenue
20
41
8,391
--
--
Reconciled Depreciation
774
770
8,830
1,578
763
Net Income from Continuing Operation Net Minority Interest
-51,026
-62,007
-113,012
-192,036
-91,130
Normalized EBITDA
-54,348
-66,045
-106,309
-190,238
-90,421
12/31/2020 - 2/12/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CUTRQ Cutera, Inc.
0.0100
+26.58%
 
TLSI TriSalus Life Sciences, Inc.
5.73
+1.42%
 
SIBN SI-BONE, Inc.
14.41
+0.14%
 
XTNT Xtant Medical Holdings, Inc.
0.5100
+6.25%
 
SGHT Sight Sciences, Inc.
3.2200
-2.13%
 
HSDT Helius Medical Technologies, Inc.
0.2920
-2.24%
 
BVS Bioventus Inc.
7.65
-1.03%
 
LAB Standard BioTools Inc.
1.1600
-5.69%
 
VTAK Catheter Precision, Inc.
0.2898
+1.76%
 
BBNX Beta Bionics, Inc.
10.96
-0.90%